55878-45-0

Basic information

• Product Name: 2,6-Dimethoxy-4-pyrimidinecarboxylic acid methyl ester
• Synonyms: 2,6-Dimethoxy-4-pyrimidinecarboxylic acid methyl ester;Methyl 2,6-diMethoxypyriMidine-4-carboxylate;4-Pyrimidinecarboxylic acid, 2,6-dimethoxy-, methyl ester;2,6-Dimethoxypyrimidine-4-Carboxylic Acid Methyl Ester(WXC03002)
• CAS NO: 55878-45-0
• Molecular Formula: C₈H₁₀N₂O₄
• Molecular Weight: 198.18
• Mol File: 55878-45-0.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 327.8°C at 760 mmHg
• Flash Point: 152.1°C
• Appearance: /
• Density: 1.225g/cm³
• Vapor Pressure: 0.000197mmHg at 25°C
• Refractive Index: 1.499
• CAS DataBase Reference: 2,6-Dimethoxy-4-pyrimidinecarboxylic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 2,6-Dimethoxy-4-pyrimidinecarboxylic acid methyl ester(55878-45-0)
• EPA Substance Registry System: 2,6-Dimethoxy-4-pyrimidinecarboxylic acid methyl ester(55878-45-0)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 55878-45-0(Hazardous Substances Data)

Usage

General Description

2,6-Dimethoxy-4-pyrimidinecarboxylic acid methyl ester is a chemical compound with the molecular formula C9H11N3O4. It is an ester derivative of pyrimidinecarboxylic acid, with two methoxy groups attached to the 2 and 6 positions of the pyrimidine ring. This chemical is often used as an intermediate in the synthesis of pharmaceuticals, agrochemicals, and other organic compounds. It has potential applications in the development of new drugs and can also be used as a building block in organic synthesis. However, it is important to handle this compound with care, as it may present health and environmental hazards if not used properly.

InChI:InChI=1/C8H10N2O4/c1-12-6-4-5(7(11)13-2)9-8(10-6)14-3/h4H,1-3H3

Upstream product

• 65-86-1 orotic acid 
• 67-56-1 methanol 
• 26830-94-4 2,4-dichloropyrimidine-6-carboxylic acid chloride 
• 6299-85-0 2,6-dichloropyrimidine-4-carboxylic acid methyl ester 

Downstream Products

• 79115-67-6 2,4-dimethoxy-5-(3'-tetrahydropyranyloxyprop-1'-yn)-6-carbomethoxypyrimidine 
• 214899-52-2 phenylmethyl 2-[3-hydroxy-3-[4,6-dimethoxy-2-pyrimidinyl]-1-propynyl]-1(2H)-pyridinecarboxylate 
• 214899-68-0 6-[2-bromo-1-oxo-3-[2-N-[[(phenylmethoxy)carbonyl]amino][(phenylmethoxy)carbonylimino]methyl]piperidinyl]-2,4-dimethoxypyrimidine 
• 214899-64-6 6-[1-oxo-3-[2-N-[[[(phenylmethoxy)carbonyl]amino][(phenylmethoxy)carbonylimino]methyl]piperidinyl]propyl]-2,4-dimethoxypyrimidine 
• 214899-68-0 ([(Z)-Benzyloxycarbonylimino]-{2-[2-bromo-3-(2,6-dimethoxy-pyrimidin-4-yl)-3-oxo-propyl]-piperidin-1-yl}-methyl)-carbamic acid benzyl ester 
• 214899-64-6 ([(Z)-Benzyloxycarbonylimino]-{2-[3-(2,6-dimethoxy-pyrimidin-4-yl)-3-oxo-propyl]-piperidin-1-yl}-methyl)-carbamic acid benzyl ester 
• 664981-82-2 6,7-dihydro-5-tert-butyldiphenylsilyloxy-3-methoxy-7-methylenepyrrolo[1,2-c]pyrimidin-1(5H)-one 

Relevant articles and documents

Aminopyrimidine Kinase Inhibitors

Disclosed are compounds, pharmaceutical compositions containing those compounds, and uses of the compounds and compositions as modulators of casein kinase 1 (e.g., CK1γ), casein kinase 2 (CK2), Pim 1, Pim2, Pim3, the TGFβ pathway, the Wnt pathway, the JAK

Total synthesis of (±)-cylindrospermopsin

The first total synthesis of the novel hepatotoxin (±)- cylindrospermopson (1) has been accomplished in 20 steps from 4-methoxy-3- methylpyridine (12) in 3.5% overall yield. The substituted piperidine A ring 19 was generated stereospecifically by a four-step sequence using the addition of trimethylsilylethynylmagnesium bromide to 12 to give 16 and stereospecific addition of vinylcuprate to 16 to form 17. The reaction of diamine 26 with cyanogen bromide produced the cyclic guanidine C ring of 27. The key step in the synthesis was bromination of ketone 31, followed by hydrogenation to liberate the free guanidine, which underwent an intramolecular S(N)2 reaction to form the tetrahydropyrimidine ring B of 32. Further hydrogenation reduced the ketone to yield 42% of 32 containing the fully functionalized tricyclic system and protected hydroxymethyluracil side chain of cylindrospermopsin. Hydrolysis of the pyrimidine in concentrated hydrochloric acid and selective monosulfation completed the synthesis of cylindrospermopsin.